speb/financial-data huggingface dataset:
SICAGEN.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 22200000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -54100000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -52700000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 190100000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 8099100000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 105400000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 3900000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 3900000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -2400000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 71300000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -361800000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 0.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 13400000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 59600000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 102800000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Share Issued: 39571684.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Special Income Charges: 75900000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 4395600000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 4392800000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 13398243.99
SICAGEN.NS income_statement (annual, 2023-03-31) — Tax Provision: 38200000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.18
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 61500000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -23300000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Total Assets: 6292800000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 4395600000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Total Debt: 1212400000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 4395600000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Total Expenses: 8735400000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 1897200000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 2168200000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 166300000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 6200000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 1800000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 75900000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 75900000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Work In Process: 43800000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Working Capital: 2393700000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Write Off: -65400000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — +Operating Expense: 604800000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — +Total Revenue: 7898100000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 921500000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 2493200000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1028900000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 2944400000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -68800000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 12200000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 727800000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 39571684.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Basic EPS: 2.66
SICAGEN.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 31500000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 865900000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -42100000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 166000000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 395700000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 51500000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 365800000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -23700000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 51500000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 135100000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -16100000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Change In Payable: 496300000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -631800000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -16500000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 20000000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Common Stock: 395700000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 4596700000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 7000000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 7111100000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Current Assets: 5038400000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 41300000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Current Debt: 1041300000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1082600000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 1600000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 2455000000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 12900000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Depreciation: 97700000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 97700000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 97700000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 97700000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 39571684.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Diluted EPS: 2.66
SICAGEN.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 105200000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 3300000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 50500000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — EBIT: 239600000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — EBITDA: 337300000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — End Cash Position: 51500000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -199200000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 1167500000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 203900000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -9700000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 5200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 57600000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 2300000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2562000000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 2386900000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Gross Profit: 787000000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 248100000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Interest Expense: 101200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 101200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Interest Income: 51700000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 51700000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -101200000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 9700000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Inventories Adjustments Allowances: 0.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Inventory: 1310800000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 5638000000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -26800000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 43000000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 727800000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 666800000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 124700000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 0.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 124700000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: 0.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 200000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 833400000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Net Debt: 989800000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 800000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Net Income: 105200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 105200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 105200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 105200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 105200000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 138400000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 105200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Net Interest Income: -54800000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -65200000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -30300000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 0.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -54800000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Net PPE: 1358000000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -21800000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -30300000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 4594400000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 100000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 50000000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 4300000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 64200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 345500000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Normalized Income: 111432947.98
SICAGEN.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 246000000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Operating Income: 182200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Operating Revenue: 7898100000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 39571684.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 106800000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 18700000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 4201000000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 2300000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 49500000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 32500000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 2700000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 9500000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 190700000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Other Properties: 13800000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 292300000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 314300000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Other Special Charges: 5200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Payables: 924800000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 12900000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 94500000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Pretax Income: 138400000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 8900000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -152700000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -42100000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 105800000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 7111100000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 97700000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 1900000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 1900000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: 0.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 93100000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -201700000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 87500000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 20300000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 62800000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 120400000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Share Issued: 39571684.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Special Income Charges: -8200000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 4596700000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 4594400000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -1967052.02
SICAGEN.NS income_statement (annual, 2024-03-31) — Tax Provision: 33200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.24
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 21600000.00
SICAGEN.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -28300000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Total Assets: 7233700000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 4596700000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Total Debt: 1207300000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 4596700000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Total Expenses: 7715900000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 2637000000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 2195300000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 182000000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 5300000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 1600000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -8200000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -8200000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Work In Process: 37500000.00
SICAGEN.NS balance_sheet (annual, 2024-03-31) — Working Capital: 2583400000.00
SICAGEN.NS income_statement (annual, 2024-03-31) — Write Off: 3000000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 408400000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 2215800000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 11700000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 896000000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 166000000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 395700000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 65400000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 590700000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 395700000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 4870200000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 0.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 4669000000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 29100000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 1331100000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1360200000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 1912700000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 8100000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 2100000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 1369800000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 1309000000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 6201300000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 42800000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 896000000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 136900000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 136900000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 4500000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 1265700000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 1369800000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 4868100000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 56500000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 39571684.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 499500000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 51300000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 4474500000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 2100000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 3900000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 2700000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 1369800000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 525300000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Payables: 413800000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 39571684.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 4870200000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 4868100000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 42300000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 6983600000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 4870200000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 1497100000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 4870200000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 2113400000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 2314600000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 200700000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 5400000.00
SICAGEN.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 2756300000.00
SICAGEN.NS income_statement (quarterly, 2024-12-31) — Other Special Charges: -21400000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — +Operating Expense: 770200000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 190100000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — +Total Revenue: 8914100000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2515200000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 428400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 428400000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2285800000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2285800000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1005400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1005400000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 2944400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2944400000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -80700000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -80700000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 8400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 8400000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 788200000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 788200000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 39606481.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 39700000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Basic EPS: 4.32
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 1.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 51500000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 915700000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 915700000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -38000000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 160300000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 160300000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 395700000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 395700000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 67600000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 67600000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 581500000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 581500000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -23700000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 67600000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 67600000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 16000000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 269700000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Change In Payable: -515800000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 172800000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -57300000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 16100000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Common Stock: 395700000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 395700000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 4839900000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 4839900000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 0.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 0.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 7898600000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2254100000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Current Assets: 5018900000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 5018900000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 42200000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 42200000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1318100000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1318100000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1360300000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1360300000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 17400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 17400000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 2195600000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2195600000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 15000000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 15000000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Depreciation: 105000000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 105000000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 105000000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 35100000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 105000000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 35100000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 39606481.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 39700000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Diluted EPS: 4.32
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 171100000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 39700000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 3000000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 3000000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 9700000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — EBIT: 352000000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — EBIT: 95000000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — EBITDA: 457000000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — EBITDA: 130100000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — End Cash Position: 67600000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -173600000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 1105400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 1105400000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 296600000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -9700000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 7000000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 36200000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1900000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1900000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2366500000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2366500000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 2335900000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2335900000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Gross Profit: 1015500000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 261100000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 257100000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 257100000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Interest Expense: 110200000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 30700000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 110200000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 30700000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Interest Income: 58600000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 58600000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -104200000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 60200000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Inventory: 1294800000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 1294800000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 6158000000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 6158000000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -144900000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 42500000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 42500000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 788200000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 788200000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 663300000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 663300000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 118100000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 118100000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 118100000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 118100000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 4800000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 4800000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 742800000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 742800000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Net Debt: 1250500000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 1250500000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 27100000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Net Income: 171100000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Net Income: 39700000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 171100000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 39700000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 171100000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 39700000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 171100000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 39700000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 171100000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 39700000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 220400000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 171100000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 39700000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Net Interest Income: -110200000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -30700000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -206800000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -110200000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -30700000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Net PPE: 1330500000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 1330500000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -8000000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 0.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 4838000000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 4838000000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 100000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 100000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 55700000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 55700000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 4800000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 4800000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 34900000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 34900000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 435600000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 130100000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Normalized Income: 155957154.67
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 39700000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 334600000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Operating Income: 245300000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Operating Income: 71000000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Operating Revenue: 8914100000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2515200000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 39571684.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 39571684.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 102700000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 102700000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 21400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 21400000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 4444200000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 4444200000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1900000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1900000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 45600000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 4200000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 4200000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 2700000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 2700000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 85300000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 24000000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 383000000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 83600000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Other Properties: 14100000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 14100000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 289600000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 289600000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 513900000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 513900000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Other Special Charges: -14800000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Payables: 431400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Payables: 431400000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15000000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15000000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 94800000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 94800000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Pretax Income: 241800000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 64300000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 34600000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -206800000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -38000000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 151300000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 151300000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 7898600000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2254100000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 105000000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 35100000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 1000000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 1000000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 99400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 99400000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -47500000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -47500000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 0.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 30000000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 72500000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 108700000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Share Issued: 39571684.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 39571684.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Special Income Charges: 21400000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 4839900000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4839900000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 4838000000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4838000000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 6257154.67
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Tax Provision: 70700000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 24600000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.29
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.38
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 4800000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 4800000.00
SICAGEN.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -38100000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Total Assets: 7216900000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 7216900000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 4839900000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4839900000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1478400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1478400000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 4839900000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4839900000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Total Expenses: 8668800000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 2444200000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 2377000000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2377000000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 2198000000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2198000000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 181400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 181400000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 6000000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 17400000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 17400000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 21400000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 21400000.00
SICAGEN.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Work In Process: 38100000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 38100000.00
SICAGEN.NS balance_sheet (annual, 2025-03-31) — Working Capital: 2823300000.00
SICAGEN.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 2823300000.00
SICAGEN.NS income_statement (annual, 2025-03-31) — Write Off: 7500000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 192100000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2045400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 39478261.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.15
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1779800000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 23900000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 23900000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 39478261.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.15
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 45400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — EBIT: 92700000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — EBITDA: 116600000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 265600000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 30400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 30400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Net Income: 45400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 45400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 45400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 45400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 45400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 45400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -30400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -30400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 116600000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 45400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Operating Income: 73500000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2045400000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 19200000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 95900000.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
SICAGEN.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 62300000.00